Duck Creek Technologies Selected to Deliver MDA National’s New Policy Admin, Billing and Data Solutions
Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment Notified -
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors